Literature DB >> 8481624

HLA-DR3 and HLA-DR5 confer risk for autoantibody positivity against the thyroperoxidase (mic-TPO) antigen in healthy blood donors.

B O Boehm1, P Kühnl, C Löliger, U Ketzler-Sasse, G Holzberger, S Seidl, R Bäuerle, E Schifferdecker, K H Usadel.   

Abstract

The prevalence of circulating autoantibodies against thyroperoxidase (mic-TPO) was determined in 3,000 healthy blood donors (age range: 23 to 60 years) from the Hamburg area. Of the blood donors, 153 (5.1%) were found to have high titer of mic-TPO (> 350 IU/ml). Only two autoantibody positive subjects (0.06%) were chemically hyper- and hypothyroid, respectively. Analysis of HLA-DR specificities revealed that HLA-DR specificities DR3 and DR5 were significantly increased when compared to controls (n = 1,863). Comparison of the autoantibody-positive probands with a group of disease controls, i.e., Graves' patients and patients with lymphocytic thyroiditis, revealed a higher prevalence of HLA-DR3-positive HLA haplotypes in the disease controls when compared to autoantibody positives. Individuals with a mic-TPO level greater than 2,000 IU/ml were almost exclusively found to have one HLA-DR3 or HLA-DR5 positive HLA haplotype. We conclude that a high prevalence of high-titer mic-TPO can be found in healthy blood donors. Circulating signs of thyroid autoimmunity were associated with HLA specificities also found to be associated with autoimmune thyroid diseases.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8481624     DOI: 10.1007/bf00180105

Source DB:  PubMed          Journal:  Clin Investig        ISSN: 0941-0198


  22 in total

1.  HL-A8: a genetic link with thyrotoxicosis.

Authors:  S Whittingham; P J Morris; F I Martin
Journal:  Tissue Antigens       Date:  1975-07

2.  Precipitating and complement-fixing antibodies in Hashimoto's disease.

Authors:  W R TROTTER; G BELYAVIN; A WADDAMS
Journal:  Proc R Soc Med       Date:  1957-11

3.  Nomenclature for factors of the HLA system, 1991. WHO Nomenclature Committee for factors of the HLA system.

Authors:  J G Bodmer; S G Marsh; E D Albert; W F Bodmer; B Dupont; H A Erlich; B Mach; W R Mayr; P Parham; T Sasazuki
Journal:  Tissue Antigens       Date:  1992-04

4.  Development of thyroid autoimmunity.

Authors:  K Aho; A Gordin; T Palosuo; J Takala
Journal:  Acta Endocrinol (Copenh)       Date:  1985-01

5.  Thyroid antibodies in blood donors: prevalence and clinical significance.

Authors:  T Bjøro; P I Gaarder; E B Smeland; L Kornstad
Journal:  Acta Endocrinol (Copenh)       Date:  1984-03

6.  Enzyme-linked immunosorbent microassay and hemagglutination compared for detection of thyroglobulin and thyroid microsomal autoantibodies.

Authors:  S H Roman; F Korn; T F Davies
Journal:  Clin Chem       Date:  1984-02       Impact factor: 8.327

7.  Antibodies to the M(r) 64,000 (64K) protein in islet cell antibody positive non-diabetic individuals indicate high risk for impaired beta-cell function.

Authors:  J Seissler; B Hering; W Richter; M Glück; N Yassin; R G Bretzel; B O Boehm; K Federlin; W A Scherbaum
Journal:  Diabetologia       Date:  1992-06       Impact factor: 10.122

8.  Prediction of therapeutic response to radioactive iodine in Graves' disease using TSH-receptor antibodies and HLA-status.

Authors:  T F Davies; M Platzer; N R Farid
Journal:  Clin Endocrinol (Oxf)       Date:  1982-02       Impact factor: 3.478

9.  The level and the persistence of islet cell antibodies in healthy schoolchildren are associated with polymorphic residues of the HLA-DQ beta chain.

Authors:  B O Boehm; J Seissler; M Glück; B J Manfras; H Thomas; K Schmidt; W A Rudert; K H Usadel; M Trucco; W A Scherbaum
Journal:  Dis Markers       Date:  1991 Sep-Oct       Impact factor: 3.434

10.  HLA-DR3 and HLA-DR5 associated thyrotoxicosis--two different types of toxic diffuse goiter.

Authors:  H Schleusener; G Schernthaner; W R Mayr; P Kotulla; U Bogner; R Finke; H Meinhold; K Koppenhagen; K W Wenzel
Journal:  J Clin Endocrinol Metab       Date:  1983-04       Impact factor: 5.958

View more
  3 in total

Review 1.  Genetic susceptibility in type 1 diabetes and its associated autoimmune disorders.

Authors:  Akane Ide; George S Eisenbarth
Journal:  Rev Endocr Metab Disord       Date:  2003-09       Impact factor: 6.514

2.  Thyroid disorders in children and adolescents with type 1 diabetes mellitus in isfahan, iran.

Authors:  Samaneh Khanpour Ardestani; Ammar Hassanzadeh Keshteli; Noushin Khalili; Mahin Hashemipour; Reihaneh Barekatain
Journal:  Iran J Pediatr       Date:  2011-12       Impact factor: 0.364

3.  Thyroid abnormalities in Egyptian children and adolescents with type 1 diabetes mellitus: A single center study from Upper Egypt.

Authors:  Kotb Abbass Metwalley; Abdel-Rahman Abdel-Hamed El-Saied
Journal:  Indian J Endocrinol Metab       Date:  2014-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.